Blumberger Liba, Calo William, Mallinson Daniel J, Liu Guodong, Leslie Douglas L
Penn State College of Medicine Hershey Pennsylvania USA.
Penn State Cancer Institute Hershey Pennsylvania USA.
Psychiatr Res Clin Pract. 2024 Jun 6;6(3):94-103. doi: 10.1176/appi.prcp.20230080. eCollection 2024 Fall.
To combat the heightened risk of opioid overdose death for individuals with criminal justice involvements, enhanced access to Medicaid remains paramount. This study examines the effect of a 2017 policy change in Pennsylvania that allowed for suspension, rather than termination, of Medicaid coverage while in prison on post-release opioid overdose mortality risk (OOMR) for adults released from Pennsylvania prisons.
This retrospective cohort study utilizes administrative records from the Pennsylvania Department of Corrections for adults ≥18 years diagnosed with opioid use disorder (OUD) released in either 2015 or 2018. Death certificate data were used to compare OOMR within a year after release, both prior to and following the policy change. Demographic, treatment, and death characteristics were assessed with bivariate analyses. Multivariable logistic regressions were used to examine the association between qualification of Medicaid suspension and post-release crude mortality and OOMR.
Qualification for Medicaid suspension was not associated with a significant decrease in OOMR (OR = 0.82, 95% CI [0.47-1.46]) or crude mortality (OR = 1.02, 95% CI [0.67-1.57]) within 1 year after prison release for individuals diagnosed with OUD. In addition, the risk of opioid overdose mortality after release from prison for adults with an OUD increased from 2015 to 2018 (0.6%-1.7%; < 0.0001), particularly from synthetic narcotics (57.1%-83.1%, < 0.001), and drug overdose remained the leading cause of death (74.0%) within the initial year of release.
These findings underscore the need for ongoing research in overdose prevention tailored to criminal justice populations. This includes a deeper analysis of policies intended to enhance post-release insurance continuity and their effect on individuals diagnosed with OUD after prison release.
为降低有刑事司法涉案经历者阿片类药物过量致死的风险,增加医疗补助的可及性至关重要。本研究考察了宾夕法尼亚州2017年一项政策变更的影响,该政策允许在服刑期间暂停而非终止医疗补助覆盖范围,这对从宾夕法尼亚州监狱释放的成年人出狱后阿片类药物过量致死风险(OOMR)的影响。
这项回顾性队列研究利用了宾夕法尼亚州惩教部的行政记录,研究对象为2015年或2018年释放的年龄≥18岁且被诊断为患有阿片类药物使用障碍(OUD)的成年人。死亡证明数据用于比较政策变更前后释放后一年内的OOMR。通过双变量分析评估人口统计学、治疗和死亡特征。多变量逻辑回归用于检验医疗补助暂停资格与释放后粗死亡率和OOMR之间的关联。
对于被诊断为OUD的个体,医疗补助暂停资格与出狱后1年内OOMR(比值比[OR]=0.82,95%置信区间[CI][0.47-1.46])或粗死亡率(OR=1.02,95%CI[0.67-1.57])的显著降低无关。此外,2015年至2018年期间,患有OUD的成年人出狱后阿片类药物过量致死风险增加(从0.6%增至1.7%;P<0.0001),尤其是来自合成麻醉品的风险(从57.1%增至83.1%,P<0.001),且药物过量在释放后的第一年仍然是主要死因(74.0%)。
这些发现强调了针对刑事司法人群开展过量预防持续研究的必要性。这包括对旨在增强释放后保险连续性的政策及其对出狱后被诊断为OUD的个体的影响进行更深入的分析。